Abstracts O 014–O 118

Autor: KL Cheung, T. J. Butler, FT Yang, P O'Brien, M Ferguson-Smith, CJ Harrison, M Gregson

Publikováno v: Cytogenetic and Genome Research. 85:9-34

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0d78540e83820760adc3ae2e1674c9ba
https://doi.org/10.1159/000015274

A chromosome 14q11/TCR alpha/delta specific yeast artificial chromosome improves the detection rate and characterization of chromosome abnormalities in T-lymphoproliferative disorders

Autor: Ka, Rack, Cornélis F, Radford-Weiss I, Bernheim A, Cj, Harrison, Olivier Hermine, Prieur M, Vekemans M, Ea, Macintyre

Publikováno v: Europe PubMed Central

The rate of detection of chromosome abnormalities in T-cell proliferations is lower than that observed in B-cell malignancies. The former frequently involve the TCR alpha/delta locus at chromosome band 14q11. We have identified a YAC encompassing 70%

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::df2d56968d0150485a2fe587f91c8383
https://pubmed.ncbi.nlm.nih.gov/9242557

Prognostic significance of the balanced t(1;19) and unbalanced der(19)t(1;19) translocations in acute lymphoblastic leukemia

Autor: Lm, Secker-Walker, Berger R, Fenaux P, Jl, Lai, Brigitte Nelken, Garson M, Pm, Michael, Hagemeijer A, Cj, Harrison, Kaneko Y

Publikováno v: Europe PubMed Central

The recurring chromosomal 1;19 translocation in acute lymphoblastic leukemia (ALL) occurs in balanced t(1;19) (q23;p13) and unbalanced, -19, +der(19)t(1;19)(q23;p13) forms. The clinical features and outcome were compared for 30 patients with the t(1;

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::e401754a2fe766cfa2039875a90e82a4
http://europepmc.org/abstract/med/1593901

Antiviral Use Among Children Hospitalized With Laboratory-Confirmed Influenza Illness: A Prospective, Multicenter Surveillance Study.

Autor: Antoon JW; Vanderbilt University Medical Center, Nashville, Tennessee, USA., Amarin JZ; Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Epidemiology Doctoral Program, Vanderbilt University, Nashville, Tennessee, USA., Hamdan O; Vanderbilt University Medical Center, Nashville, Tennessee, USA., Stopczynski T; Vanderbilt University Medical Center, Nashville, Tennessee, USA., Stewart LS; Vanderbilt University Medical Center, Nashville, Tennessee, USA., Michaels MG; UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA., Williams JV; UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., Klein EJ; Seattle Children's Research Institute, Seattle, Washington, USA., Englund JA; Seattle Children's Research Institute, Seattle, Washington, USA., Weinberg GA; University of Rochester School of Medicine and Dentistry, Rochester, New York, USA., Szilagyi PG; University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.; UCLA Mattel Children's Hospital and Department of Pediatrics, University of California at Los Angeles, Los Angeles, California, USA., Schuster JE; Children's Mercy Hospital and University of Missouri-Kansas City, Kansas City, Missouri, USA., Selvarangan R; Children's Mercy Hospital and University of Missouri-Kansas City, Kansas City, Missouri, USA., Harrison CJ; Children's Mercy Hospital and University of Missouri-Kansas City, Kansas City, Missouri, USA., Boom JA; Texas Children's Hospital and Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA., Sahni LC; Texas Children's Hospital and Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA., Muñoz FM; Texas Children's Hospital and Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA., Staat MA; Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., Schlaudecker EP; Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., Chappell JD; Vanderbilt University Medical Center, Nashville, Tennessee, USA., Clopper BR; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Moline HL; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Campbell AP; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Spieker AJ; Vanderbilt University Medical Center, Nashville, Tennessee, USA., Olson SM; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Halasa NB; Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Dec 17. Date of Electronic Publication: 2024 Dec 17.

Risk Stratification in Older Intensively Treated Patients With AML.

Autor: Versluis J; Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands., Metzner M; MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom., Wang A; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom., Gradowska P; Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands.; HOVON Foundation, Rotterdam, the Netherlands., Thomas A; Centre for Trials Research, College of Biomedical & Life Sciences, Cardiff University, Cardiff, United Kingdom., Jakobsen NA; MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom., Kennedy A; MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom., Moore R; MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom., Boertjes E; Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands., Vonk CM; Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands., Kavelaars FG; Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands., Rijken M; Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands., Gilkes A; School of Medicine, Cardiff University, Cardiff, United Kingdom., Schwab C; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Beverloo HB; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands., Manz M; Department of Hematology, University Hospital Zurich, Zurich, Switzerland., Visser O; Department of Hematology, Isala Hospital, Zwolle, the Netherlands., Van Elssen CHMJ; Maastricht University Medical Center, Maastricht, the Netherlands., de Weerdt O; Antonius Hospital, Nieuwegein, the Netherlands., Tick LW; Maxima Medical Center, Eindhoven, the Netherlands., Biemond BJ; Amsterdam UMC, Location AMC, Cancer Center Amsterdam, Amsterdam, the Netherlands., Vekemans MC; Cliniques Universitaires Saint-Luc, Brussels, Belgium., Freeman SD; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Harrison CJ; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Cook JA; Oxford Clinical Trials Research Unit, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom., Dennis M; The Christie NHS Foundation Trust, Manchester, United Kingdom., Knapper S; School of Medicine, Cardiff University, Cardiff, United Kingdom., Thomas I; Centre for Trials Research, College of Biomedical & Life Sciences, Cardiff University, Cardiff, United Kingdom., Craddock C; Warwick Clinical Trials Unit, University of Warwick, Warwick, United Kingdom., Ossenkoppele GJ; Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands., Löwenberg B; Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands., Russell N; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Valk PJM; Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands., Vyas P; MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.; Department of Haematology, Oxford University Hospitals NHS Trust and Oxford Biomedical Centre, Oxford, United Kingdom.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Dec; Vol. 42 (34), pp. 4084-4094. Date of Electronic Publication: 2024 Sep 04.